News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Ruzanna Papyan: Exclusive Educational Session on Immune Landscape of Neuroblastoma
Ruzanna Papyan/LinkedIn
Feb 27, 2025, 17:16

Ruzanna Papyan: Exclusive Educational Session on Immune Landscape of Neuroblastoma

Ruzanna Papyan, Pediatric Oncologist at the Pediatric Cancer and Blood Disorders Center of Armenia, shared a post on LinkedIn:

“Join Us for an Exclusive Educational Session!

We’re excited to invite you to an insightful session organized by the Global Neuroblastoma Network, featuring Jan Molenaar from the Princess Máxima Center for Pediatric Oncology on:

Immune Landscape of Neuroblastoma

Date: Thursday, December 27, 2025
Time: 08:30 AM EST

This session is a must-attend for anyone interested in neuroblastoma research, pediatric oncology, and cutting-edge immunotherapy developments.
 Don’t miss this opportunity to engage with global leaders in neuroblastoma research!

Tag your colleagues and spread the word!”

cancer fight against cancer Global awareness Global fight against cancer global leaders Global Neuroblastoma Network Jan Molenaar neuroblastoma OncoDaily Oncology pediatric oncology Princess Máxima Center Ruzanna Papyan
Special Coverage
Blog
Feb 27, 2025, 17:16
Ruzanna Papyan: Exclusive Educational Session on Immune Landscape of Neuroblastoma
Blog
Feb 27, 2025, 17:13
Submission deadline is approaching for the late-breaker abstracts for MASCC25
Blog
Feb 27, 2025, 17:10
Fertility Preservation Is Key in Survivorship - Childhood Cancer International
Blog
Feb 27, 2025, 17:01
Chris Boshoff: Pfizer has entered into a clinical trial collaboration with Summit Therapeutics
Blog
Feb 27, 2025, 16:55
Daniel De Carvalho: Chronic viral mimicry after p53 loss enables immune evasion in early ovarian cancer
Drugs
Feb 27, 2025, 14:43
Astrazeneca Announced New Data on Phase III SERENA-6 trial with Camizestrant for 1st Line Treatment of HR-Positive and HER2-Negative Advanced Breast Cancer
Science
Feb 27, 2025, 13:45
Alessandra Vaccaro: What can we do as a community to improve clinical outcomes?
Science
Feb 27, 2025, 13:40
Robert Brodsky: Haploidentical Bone Marrow Transplantation for Sickle Cell Disease
Blog
Feb 27, 2025, 13:36
No child with cancer should die because they lack access to life-saving medicines - United Nations Office at Geneva
Blog
Feb 27, 2025, 13:29
32 million women caregivers in Europe at heightened risk of poverty - European Cancer Organisation
Blog
Feb 27, 2025, 13:26
Noemi Reguart: WCLC 2025 - Where Innovation Meets Collaboration
Societies
Feb 27, 2025, 13:24
Introducing the EU PHARMA ADVOCACY Series - SIOP Europe